Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2006; 12(28): 4504-4510
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4504
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4504
Table 2 Bone analysis at 16 wk
| Whole body BMD mg/cm2 | High resolution BMD mg/cm2 | Femur length (mm) | Mid-shaft thickness (mm) | Femur mass (g)/kg body mass | Ca2+ mg/g bone | Hyp/g bone | |
| Control (n = 12) | 211.7 ± 9 | 379.7 ± 46 | 42.8 ± 1.1 | 4.7 ± 0.3 | 1.49 ± 0.1 | 260 ± 7 | 3576 ± 1980 |
| Control + rapamycin (n = 12) | 210.0 ± 8 | 377.2 ± 43 | 42.8 ± 1.3 | 4.7 ± 0.3 | 1.53 ± 0.1 | 258 ± 9 | 6104 ± 1600a |
| PSS (n = 11) | 201.9 ± 8a | 309.3 ± 63a | 36.6 ± 0.6b | 4.1 ± 0.3a | 1.80 ± 0.2a | 289 ± 5b | 2038 ± 878 |
| PSS + Rapamycin (n = 10) | 210.5 ± 17 | 334. ± 64 | 37.3 ± 1b | 3.8 ± 0.3b | 1.81 ± 1.37b | 297 ± 9b | 5489 ± 1250a |
- Citation: Merwe SWVD, Conradie MM, Bond R, Olivier BJ, Fritz E, Nieuwoudt M, Delport R, Slavik T, Engelbrecht G, Kahn D, Shephard EG, Kotze MJ, Villiers NP, Hough S. Effect of rapamycin on hepatic osteodystrophy in rats with portasystemic shunting. World J Gastroenterol 2006; 12(28): 4504-4510
- URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4504.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i28.4504